Jukka Alinikula

4PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 23, 2024
The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential oncogenic activity.

Filip Šenigl, Anni Soikkeli, Salomé Prost

|Mar 27, 2023
Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma.

Anni I Soikkeli, Minna K Kyläniemi, Harri Sihto

|Dec 04, 2021
Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.

Alina Tarsalainen, Yaakov Maman, Fei-Long Meng

|Feb 13, 2018
BLIMP-1 is insufficient to induce antibody secretion in the absence of IRF4 in DT40 cells.

P M Budzyńska, M K Kyläniemi, O Lassila

Pageof 1